19 research outputs found
Amenorrhea after weight recover in anorexia nervosa: Role of body composition and endocrine abnormalities
Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum
Constitutional Negotiations in Federal Reforms: Interests, Interaction Orientation and the Prospect of Agreement
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women
Relationship between dietary restraint, binge eating, and leptin in obese women
To describe some biological, behavioural and psychological correlates of the Three-Factor Eating Questionnaire, and to determine the relationship between dietary restraint, binge eating, and leptin among obese women seeking treatment
Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men
Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men. Lejeune MP, Hukshorn CJ, Saris WH, Westerterp-Plantenga MS. Department of Human Biology, Maastricht University, Maastricht, The Netherlands. [email protected] OBJECTIVE: To examine the effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB protein) treatment in overweight men. DESIGN: A randomized double-blind placebo-controlled trial in 24 overweight men (BMI: 28.8+/-0.3 kg/m(2); age: 34.8+/-0.9 y). PEG-OB protein (80 mg) or placebo was administered subcutaneously weekly for 6 weeks, combined with a 2.1 MJ/day energy restriction program. Dietary restraint was determined by the Three-Factor Eating Questionnaire before and after treatment, and after 8 weeks follow-up. RESULTS: During treatment dietary restraint increased, and general hunger, resting energy expenditure and respiratory quotient decreased similarly in the PEG-OB and the placebo group. With PEG-OB treatment, additional weight loss (P<0.03) was observed. During 8 weeks follow-up, body weight increase was larger in the PEG-OB group compared to placebo (P<0.05), and body weight regain was faster. Body weight regain was inversely correlated with the increase in cognitive dietary restraint during treatment (PEG-OB group: r(2)=0.49, P<0.02; placebo group: r(2)=0.60, P=0.01). CONCLUSION: Although treatment with PEG-OB protein led to a greater body weight loss relative to placebo, weight maintenance thereafter was mainly supported by dietary restraint, which was more effective in the placebo-treated group, resulting in a slower regain of body weight